Lloyds Luxuries Ltd vs Sheel Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 16, 2026

Key Highlights

The Latest Trading Price of Lloyds Luxuries Ltd is ₹ 47 as of 16 Mar 15:30 . The P/E Ratio of Lloyds Luxuries Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Sheel Biotech Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Lloyds Luxuries Ltd changed from ₹ 94.5 crore on March 2023 to ₹ 217.16 crore on March 2025 . This represents a CAGR of 31.96% over 3 yearsThe Market Cap of Sheel Biotech Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The Dividend Payout of Lloyds Luxuries Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sheel Biotech Ltd changed from 28.46 % on March 2022 to 14.05 % on March 2025 . This represents a CAGR of -16.18% over 4 years .

About Lloyds Luxuries Ltd

Lloyds Luxuries Limited was originally incorporated as a Private Limited Company under the name of 'Lloyds Luxuries Private Limited' on October 21, 2013.
Subsequently, on December 14, 2013, Company converted into a Public Limited Company and consequently name of the Company was changed to 'Lloyds Luxuries Limited' vide a fresh Certificate of Incorporation dated January 29, 2014, issued by the Registrar of Companies, Mumbai. The Company is amongst the organized player of salon services and beauty products, focused on grooming men to perfection.
It own exclusive franchisee of Truefitt & Hill, which is an international brand offering a wide range of beauty products and salon services for men through the luxury barbershops operating across many countries.
The brand is exclusively owned by Truefitt & Hill (Gentlemen's Grooming) Limited, a company registered under the Law of England and Wales and having its office in London, United Kingdom.

About Sheel Biotech Ltd

Sheel Biotech Limited was incorporated as a Private Company as 'Sheel Biotech Private Limited' dated November 26, 1991, with the Registrar of Companies, Delhi & Haryana.
Further, Company was converted into a Public Limited Company w.e.f.
April 02, 1992. The Company was founded by Dr. Satya Narayan Chandak in 1991.
Thereafter, through his vision he led the stone of Tissue Culture lab wherein for advancement of lab he deputed two of his scientists to Netherlands for training to expand the business ventured in domestic market too and then added greenhouse division to promote protected cultivation.
The Company started the Import division in 2019 and importing tulip, glad, lilium, orchids and alstromeria.

FAQs for the comparison of Lloyds Luxuries Ltd and Sheel Biotech Ltd

Which company has a larger market capitalization, Lloyds Luxuries Ltd or Sheel Biotech Ltd?

Market cap of Lloyds Luxuries Ltd is 115 Cr while Market cap of Sheel Biotech Ltd is 111 Cr

What are the key factors driving the stock performance of Lloyds Luxuries Ltd and Sheel Biotech Ltd?

The stock performance of Lloyds Luxuries Ltd and Sheel Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lloyds Luxuries Ltd and Sheel Biotech Ltd?

As of March 16, 2026, the Lloyds Luxuries Ltd stock price is INR ₹48.0. On the other hand, Sheel Biotech Ltd stock price is INR ₹54.8.

How do dividend payouts of Lloyds Luxuries Ltd and Sheel Biotech Ltd compare?

To compare the dividend payouts of Lloyds Luxuries Ltd and Sheel Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.